95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
MINI REVIEW article
Front. Public Health
Sec. Substance Use Disorders and Behavioral Addictions
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1585533
This article is part of the Research Topic Innovations in Recovery Science: Pathways, Policies, and Platforms that Promote Thriving After Addiction View all 11 articles
Substance Use Disorder Recovery Research Opportunities: Perspectives from a Federal Interagency Workgroup
Provisionally accepted- 1 Office of National Drug Control Policy, Executive Office of the President, Washington, DC, United States
- 2 National Institute on Drug Abuse (NIH), North Bethesda, MD, United States
- 3 National Institute on Alcohol Abuse and Alcoholism (NIH), Bethesda, Maryland, United States
In 2024, the Office of National Drug Control Policy (ONDCP) convened an interagency working group (IWG) comprised of 30 federal agencies to identify proposed federal recovery research gaps and opportunities on recovery from substance use disorder (SUD). This article outlines the process undertaken to identify these research opportunities and describes four core research topic areas and three cross-cutting themes and provides the rationale for their selection. It also identifies potential pathways for recovery research, including evaluation and data collection activities, and discusses challenges and potential opportunities for recovery research.
Keywords: Recovery, remission, substance use disorder, Recovery capital, Peer recovery support services
Received: 28 Feb 2025; Accepted: 31 Mar 2025.
Copyright: © 2025 Gaumond, Martin, Hagman and Davis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Peter Gaumond, Office of National Drug Control Policy, Executive Office of the President, Washington, DC, United States
Lindsey Ann Martin, National Institute on Drug Abuse (NIH), North Bethesda, MD, United States
Brett T Hagman, National Institute on Alcohol Abuse and Alcoholism (NIH), Bethesda, 20892-9304, Maryland, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.